News for Medifast, Inc. (MED)

We view a Medifast revitalization as hinging on a steep coach network inflection. Read why we think MED stock becomes a core contrarian trade for outsized upside.

J&J Snack Foods, Lifeway Foods, and Tyson Foods emerge as the U.S. food sector’s healthiest performers. Smaller contenders leapfrog industry giants in RealRate’s latest financial strength rankings…

Shares of Medifast Inc (MED) surged 8.30% in mid-day trading on Jun 18. The stock reached an intraday high of $14.91, before settling at $14.61, up from its

Medifast (MED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Revenue: $115.7 million, a decrease of 33.8% year-over-year.Active Earning OPTAVIA Coaches: Approximately 25,400, a decrease of 32.8% from the previous year.Av

Apr 28, 2025 / 08:30PM GMTOperator Greetings, and welcome to the Medifast first quarter 2025 earnings conference call. (Operator Instructions) As a reminder, th

Revenue: $115.7 million, surpassing the estimated $110.10 million.Loss Per Share (EPS): -$0.07, better than the estimated loss of -$0.27 per share.Net Loss: $0

Discover Medifast's Q1 2025 earnings insights. Learn about their GLP-1 strategy, cost-saving measures, and projections for recovery.

Medifast, Inc. (NYSE:MED) Q1 2025 Earnings Conference Call April 28, 2025 4:30 PM ETCompany ParticipantsSteven Zenker - Vice President, Investor...

[url="]Medifast[/url] (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, [url="]OPTA[/url][url="]VIA®

In the first quarter, Medifast (MED) reported a revenue of $115.7 million, a noticeable drop from $174.7 million in the same period last year. The company's CEO

The following slide deck was published by Medifast, Inc.

Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, will announce financial results

Medifast, Inc. faces declining demand amid GLP-1 impact, struggling repositioning efforts, and earnings uncertainty. Read more about MED stock here.

All three major U.S. indices are red in Wednesday's midday trading as investors weighed President Donald Trump's proposed tariffs on auto imports, pharmaceuticals and semiconductors.

Revenue: $119 million for Q4 2024, a decrease of 37.7% year-over-year.Gross Profit: $88.2 million, down 37.6% year-over-year; Gross profit margin improved to 7

Feb 18, 2025 / 09:30PM GMTOperator Greetings, and welcome to the Medifast fourth-quarter 2024 earnings conference call. (Operator Instructions) As a reminder, t

Discover how Medifast navigates GLP-1 market shifts with innovative products like OPTAVIA ASCEND, cost-saving initiatives, and growth strategies for 2025.

Medifast, Inc. (NYSE:MED) Q4 2024 Earnings Conference Call February 18, 2025 4:30 PM ETCompany ParticipantsSteven Zenker - Vice President, Investor...